Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to restore the body’s innate immune system, has enrolled 10 of the 20 patients with moderate to severe Crohn’s disease...
Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient numbers and to conduct their study to the highest quality possible. Every sponsor faces the same problems, these being the lack of high performing sites available, with...
EU-funded NEPHSTROM project announces patients with diabetic kidney disease are now being enrolled in a clinical trial studying the use of a novel stromal cell immunotherapy NEPHSTROM, a large European Union Horizon 2020-funded research project coordinated by NUI...
eClinicalHealth Limited, developers of ClinpalTM, the decentralized clinical trial platform, and Dreem, a sleep neurotech company, announce the successful completion of one clinical trial validation study (Octave), and the launch of a series of clinical trials in...
NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH). Viz.ai, Inc., a leading applied artificial intelligence company in...
Email
Text